FDAs Katie Park said that there is a lack of safety and efficacy data to support using emideltide for treating insomnia, narcolepsy and opioid use disorder. During the open public hearing, witnesses presented mixed views on whether this compound should be approved
He has extraordinary bedside manner
As of October 2025, there were 193 innovative drug candidates in development for obesity, up from 107 in August 2024External link, according to IQVIA
Mobile IV Therapy Across Phoenix and the Valley, Day or Night Platinum IV Therapy delivers hydration and relief right to your door in Gilbert
They introduced an innovative approach combining Long Short-Term Memory (LSTM) learning models with Slow Feature Analysis to provide a more objective evaluation of individual hypoxia tolerance and AMS vulnerability
Together, they explore why the current medical system is built to manage illness rather than create health, and what it truly means to take a proactive, data-driven approach to longevity